Background
==========

Lung adenocarcinoma (LUAD) is the common subtype of nonsmall-cell lung cancer (NSCLC), and LUAD occurs mostly in the peripheral airways of the lung \[[@b1-medscimonit-26-e922900]\]. According to global cancer statistics, LUAD accounts for almost 40% of lung cancer deaths \[[@b2-medscimonit-26-e922900]\]. Because the diagnosis of lung cancer occurs mostly at advanced stages \[[@b3-medscimonit-26-e922900]\], prognosis of patients with lung cancers has not dramatically improved in recent years, even though treatment has made good advances \[[@b4-medscimonit-26-e922900]\]. Thus, discovering new biomarkers for the identification of early LUAD is imperative.

Circular ribonucleic acids (circRNAs) are subcategorized as a subtype of endogenous noncoding RNA with a circular form. Essentially, circRNAs are the back-splicing products of precursor messenger RNAs (mRNAs) \[[@b5-medscimonit-26-e922900]\]. Notably, the closed structure of circRNAs makes them more stable to exonuclease digestion \[[@b6-medscimonit-26-e922900]\], thus universally existing in tissues and circulating body fluids such as serum and urine. Previous evidence has revealed the involvement of circRNAs in human diseases \[[@b7-medscimonit-26-e922900]\]. Multiple expression profiles of circRNAs have also been uncovered in tissues \[[@b8-medscimonit-26-e922900]\], peripheral whole blood \[[@b9-medscimonit-26-e922900]\], and plasma exosomes \[[@b10-medscimonit-26-e922900]\] from LUAD patients. Several circRNAs are suggested to be noninvasive diagnostic biomarkers for LUAD \[[@b11-medscimonit-26-e922900],[@b12-medscimonit-26-e922900]\].

Here, we aimed to investigate the expression and role of hsa_circ_0008193 (circ_0008193) in LUAD cells, as well as its competing endogenous RNA (ceRNA) mechanism \[[@b13-medscimonit-26-e922900]\]. Physically, circRNAs are mostly regarded as micro (mi)RNA sponges. Smoking trends have probably dictated global epidemiology of lung cancers \[[@b14-medscimonit-26-e922900]\], and miRNA (miR)-1180-3p is one of the top smoking-associated miRNAs that is associated with pulmonary function \[[@b15-medscimonit-26-e922900]\]. Tripartite motif containing 62 (TRIM62; also named as DEAR1) is a tumor suppressor in cancers, including lung cancer \[[@b16-medscimonit-26-e922900]--[@b18-medscimonit-26-e922900]\]. Hypoxia has been well recognized to be one tumor-specific microenvironment, including in lung cancers \[[@b19-medscimonit-26-e922900]\]. Collectively, we attempted to measure the interaction among circ_0008193, miR-1180-3p, and TRIM62 in LUAD cells under hypoxia.

Material and Methods
====================

Patients' information and tissue sample acquisition
---------------------------------------------------

A total of 53 paired surgical pathology specimens including tumor tissues and paired peripheral normal lung tissues was obtained from patients with LUAD in Hainan General Hospital. The specimens were snap-frozen and stored at −80°C until use. The patients had primary LUAD and received no neoadjuvant therapy before this surgery. The clinicopathological features were collected and presented in [Table 1](#t1-medscimonit-26-e922900){ref-type="table"}, and survival data were traced after surgery. This study was approved by the Ethics Committee of Hainan General Hospital in accordance with the Declaration of Helsinki, and written informed consent was received from every patient before sample collection. The patients were followed up for 5 years by telephone and the overall survival time was defined as the time from the surgery to the last follow-up or death.

Cells and cell culture
----------------------

Human LUAD cell lines A549 (cat: C0016002) and H1975 (cat: C0016013) and normal human lung epithelial cell line BEAS-2B (cat: T0007001) were purchased from AddexBio (San Diego, CA, USA). These cells were cultured in Roswell Park Memorial Institute media 1640 (RPMI; HyClone, Logan, UT, USA) with 10% fetal bovine serum (FBS; HyClone) at 37°C and 5% CO~2~.

Cell transfection
-----------------

For overexpression of circ_0008193, the full-length complementary deoxyribonucleic acid (cDNA) of circ_0008193 was cloned into pLCDH-ciR vector (GenePharma, Shanghai, China). The miR-1180-3p mimic (5′-UGUGUGGGUGCGCUCGGCCUUU-3′), small interfering (si)RNA against TRIM62 (si-TRIM62; sense 5′-CCCUGAAGGUGGUCCAUGA-3′ and antisense 5′-CGCCAAAGCGCUUCGAUGU-3′), and their negative controls miR-NC mimic (5′-GUCCAGUGAAUUCCCAG-3′) and si-NC (sense 5′-UUCUCCGAACGUGUCACGUTT-3′ and antisense 5′-ACGUGACACGUUCGGAGAATT-3′) were provided by GenePharma as well. A549 and H1975 cells were exogenously administrated with these nucleotides using Lipofectamine™3000 reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions.

Hypoxia treatment
-----------------

A549 and H1975 cells were passaged and grown to 70% confluence. Cells were then transferred in a humidified hypoxic chamber (Coy Laboratory Products, Inc, Grass Lake, MI, USA) for incubation with 1% O~2~, 5% CO~2~, and 94% N~2~ for 48 h. The control cells were cultivated in normoxic condition (20% O~2~, 5% CO~2~, and 75% N~2~).

Real-time quantitative polymerase chain reaction (RT-qPCR)
----------------------------------------------------------

Total RNA in tissues and cells was extracted using RNAiso Plus (Takara, Shiga, Japan). This RNA sample (2 μg) was treated with RNase R (2 U/μg; Epicentre Technologies, Madison, WI, USA) for 30 min at 37°C or not. The cDNA was generated using cDNA applying the PrimeScript™ RT reagent kit with genomic DNA eraser (Takara) and amplified using special primers and SYBR Premix Ex Taq (Takara). The analysis of RT-qPCR was performed on BioRad CFX96 sequence detection system (Bio-Rad, Berkeley, CA, USA) and the results were presented according to threshold cycle method, normalized to internal controls glyceraldehyde 3-phosphate dehydrogenase (GAPDH) or U6. The paired primer of

1.  circ_0008193 was 5′-ACCCTCCTGATCACCATAGC-3′ (forward) and

    5′-ATTCAGACTGGCCGATGTCA-3′ (reverse),

2.  FAM120A was 5′-AGGGCGGAGTCCAACCTAT-3′ (forward)

    and 5′-CTGGTCCTCCGACAGAAACC-3′ (reverse),

3.  miR-1180-3p was 5′-CAGAAACAGCCATCCCAGAG-3′ (forward)

    and 5′-GCCTTCAGCAGGATGTCAAT-3′ (reverse),

4.  TRIM62 was 5′-TTGATCCAAGGATGTGACATG-3′ (forward)

    and 5′-GTGACCACTGTGGACTGGG-3′ (reverse),

5.  GAPDH was 5′-CAGCCAGGAGAAATCAAACAG-3′ (forward)

    and 5′-GACTGAGTACCTGAACCGGC-3′ (reverse),

6.  and U6 was 5′-CTCGCTTCGGCAGCACATATACT-3′ (forward)

    and 5′-ACGCTTCACGAATTTGCGTGTC-3′ (reverse).

3-(4, 5-Dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide (MTT) assay
--------------------------------------------------------------------------

A549 and H1975 cells were passaged and seeded in a 96-well plate (8000 cells/well). The cells were then treated under normoxia or hypoxia for 48 h. The culture medium was removed, and 100 μL of fresh RPMI supplemented with 5 mg/mL MTT (Sigma-Aldrich, St. Louis, MO, USA) was added to each well for another 4-h incubation. After that, 150 μL of dimethyl sulfoxide (Sigma-Aldrich) was added to dissolve the formazan after discarding the supernatant. Absorbance at 490 nm (A490) was measured with a microtiter plate reader, and cell viability was the percentage of A490 values compared with the control group. All groups were repeated in four wells.

Analysis of glucose consumption and lactate production
------------------------------------------------------

Hypoxia-treated A549 and H1975 cells were starved in 0.1% glucose-free RPMI containing 0.1% FBS for 16 h. Then, to these cells was added 2-(*N*-\[7-nitrobenz-2-oxa-1,3-diazol-4-yl\] amino)-2-deoxy-d-glucose (5 μM) for 30 min, and the fluorescence intensity was read using a microplate reader (Clario Star; BMG Labtech, Ortenberg, Germany). The concentration of lactate was measured using lactate assay kit II (Invitrogen) before collection of the cell extract of hypoxic A549 and H1975 cells.

Western blotting
----------------

For total protein determination, tissues and cells were lysed in an appropriate volume of radioimmunoprecipitation (RIPA) buffer (Roche Diagnostics, Mannheim, Germany) on ice, and the supernatant was collected after centrifugation at 15 000×*g* for 20 min. Twenty micrograms of protein samples were separated by sodium dodecyl sulfate--polyacrylamide gel electrophoresis and then transferred to a polyvinylidene fluoride membrane (Millipore, Billerica, MA, USA). After incubation of the special primary antibodies for 8 h at 4°C including hexokinase II (HK2; ab227198, 1: 10 000), lactate dehydrogenase A (LDHA; ab125683, 1: 2 000), matrix metalloproteinase 2 (MMP2; ab97779, 1: 2 000), MMP9 (ab137867, 1: 1 000), TRIM62 (ab51039, 1: 1 000), and GAPDH (ab9485, 1: 2 000), the protein blots were also incubated with universal second antibodies including horseradish peroxidase-labeled anti-rabbit (ab97051, 1: 10 000) for 1 h at room temperature. Specific protein bands were detected using Super ECL plus detection reagent (Thermo Fisher Scientific, Carlsbad, CA, USA) on a western chemiluminescent imaging system (Thermo Fisher Scientific). The relative protein expression was calculated according to the gray intensity determined on Image-Pro Plus software (Media Cybernetics, Silver Spring, MD, USA).

Transwell assay
---------------

Tranwell invasion assay was performed using transwell chambers precoated with Matrigel (BD Bioscience, San Jose, CA, USA). After hypoxia or normoxia treatment, A549 and H1975 cells (8×10^4^) in RPMI without serum were plated in the upper chamber loaded in a 24-well plate, and RPMI containing 10% FBS filled the lower chamber. The transwell devices were incubated at 37°C for another 48 h, and then the cells on the lower surface were treated with 4% paraformaldehyde and stained with 0.1% crystal violet. Five randomly selected fields were captured under the microscope at 100×. Transwell migration assay was carried out with the same procedures as above using chambers free from Matrigel. All experiments were repeated at least three times.

Dual-luciferase reporter assay
------------------------------

The fragments of circ_0008193 and the 3′ untranslated region (3′-UTR) of TRIM62 containing the potential binding site of miR-1180-3p including the wild type (WT) and mutant type were separately inserted into pGL4 vectors (Promega, Madison, WI, USA). A549 and H1975 cells in a 24-well plate were cotransfected with vectors and miR-1180-3p mimic or miR-NC mimic for 48 h. Later, the cells were harvested to measure firefly and renilla luciferase activities on a dual-luciferase reporter assay system (Promega). The transfections were repeated in three wells.

RNA immunoprecipitation
-----------------------

A549 and H1975 cells were lysed in ice-cold lysis buffer, and cell lysate was collected and incubated with magnetic beads preconjugated with Argonaute2 (Ago2; ab32381, 1: 500) or immunoglobulin G (ab2410, 1: 500) antibody. The coimmunoprecipitated RNAs were digested by proteinase K before total RNA isolation. The enrichment of circ_0008193 and miR-1180-3p was measured by RT-qPCR.

Xenograft tumor experiment
--------------------------

A total of 8 male BALB/c nude mice (4--6 weeks old) were purchased from the Model Animal Research Center of Nanjing University. A549 cells (2×10^6^) were subcutaneously injected into the right flank of the mice. After 7 days, the mice were divided into two groups (*n*=4) and were intratumorally injected with pLCDH-ciR-circ_0008193 vector or empty pLCDH-ciR vector every 3.5 days. The tumor sizes including length (mm) and width (mm) were measured every 7 days. After 35 days from cell implantation, the mice were sacrificed by cervical dislocation and the xenograft tumors were dissected, weighed, and stored at −80°C. The tumor volume (mm^3^) was calculated using the formula *V*=0.5×length×width^2^. The tumor tissues were extracted by RNAiso Plus or RIPA for RT-qPCR or western blotting. The protocol used for these studies was approved by the Institutional Animal Care and Use Committee of Hainan General Hospital.

Statistical analysis
--------------------

The results were presented as mean±standard deviation, and the comparisons between two groups were analyzed by chi-square test, two-tailed Student's *t* test, or one-way analysis of variance followed by Bonferroni post hoc analysis. Statistical analysis was carried out on GraphPad Prism 7 (GraphPad, San Diego, CA, USA). The Kaplan--Meier method was used for the 5-year overall survival curve of LUAD patients, and log-rank test was used to compare the curves.

Results
=======

Expression of circ_0008193 was downregulated in human LUAD tumor tissues and cell lines
---------------------------------------------------------------------------------------

Expression of circ_0008193 in LUAD was measured, and RT-qPCR data showed a lower expression of circ_0008193 in both LUAD tumor samples (*n*=53) and cell samples (A549 and H1975) ([Figure 1A, 1B](#f1-medscimonit-26-e922900){ref-type="fig"}). Moreover, circ_0008193 expression was not affected by RNase R treatment, whereas FAM120A, the parent gene of circ_0008193, was dramatically decreased by RNase R digestion ([Figure 1C, 1D](#f1-medscimonit-26-e922900){ref-type="fig"}). Clinically, this downregulation of circ_0008193 was associated with large tumor size and lymph node metastasis as well as overall survival of LUAD patients ([Table 1](#t1-medscimonit-26-e922900){ref-type="table"}, [Figure 1E](#f1-medscimonit-26-e922900){ref-type="fig"}). Hypoxia-inducible factor 1 (HIF1) was the main oxygen sensor that regulated the adaptation to intratumoral hypoxia \[[@b20-medscimonit-26-e922900]\], and its subunit HIF1 alpha (HIF1A) was a pivotal pathway in hypoxic tumor growth and progression \[[@b21-medscimonit-26-e922900]\]. Thus, RT-qPCR also indicated that hypoxia induced HIF1A expression at high levels in A549 and H1975 cells ([Supplementary Figure 1A](#s1-medscimonit-26-e922900){ref-type="supplementary-material"}), accompanied by an even lower expression of circ_0008193 than in normoxic cells ([Figure 1F, 1G](#f1-medscimonit-26-e922900){ref-type="fig"}). These data showed a downregulation of circ_0008193 in LUAD tissues and cells, suggesting a potential role of circ_0008193 in hypoxic LUAD cells.

Upregulation of circ_0008193 suppressed cell proliferation, migration, invasion, and Warburg effect in LUAD cells under hypoxia *in vitro*
------------------------------------------------------------------------------------------------------------------------------------------

Next, the effect of circ_0008193 in LUAD cells under hypoxia was investigated*in vitro*. In response to hypoxia treatment, circ_0008193 was silenced in A549 and H1975 cells ([Figure 2A](#f2-medscimonit-26-e922900){ref-type="fig"}), and cell viability was highly induced according to MTT assay ([Figure 2B](#f2-medscimonit-26-e922900){ref-type="fig"}). The activation of oxygen-independent glycolysis has been well known in lung cancers and is called the Warburg effect \[[@b22-medscimonit-26-e922900]\]. Commercial kits revealed that glucose uptake and lactate production were facilitated by hypoxia treatment in A549 and H1975 cells ([Figure 2C, 2D](#f2-medscimonit-26-e922900){ref-type="fig"}); western blotting determined that HK2 and LDHA expression was elevated in hypoxia-treated A549 and H1975 cells ([Figure 2E, 2F](#f2-medscimonit-26-e922900){ref-type="fig"}). Hypoxia always stimulated tumor metastasis \[[@b23-medscimonit-26-e922900]\]; therefore, cell migration and invasion were measured. Transwell assay showed that migration and invasion cell numbers were significantly higher in A549 and H1975 cells under hypoxic condition ([Figure 2G--2J](#f2-medscimonit-26-e922900){ref-type="fig"}), along with increased MMP2 and MMP9 expression ([Figure 2K, 2L](#f2-medscimonit-26-e922900){ref-type="fig"}). The abovementioned outcomes together indicated that hypoxia contributed to LUAD cell proliferation, migration, invasion, and Warburg effect *in vitro*. However, with transfection of circ_0008193 overexpression vectors, RT-qPCR analysis revealed a restoration of circ_0008193 in hypoxic A549 and H1975 cells after transfection with circ_0008193 overexpression vectors ([Figure 2A](#f2-medscimonit-26-e922900){ref-type="fig"}), and this upregulation caused a diminishing effect on cell viability, glucose uptake, lactate production, numbers of migrating and invading cells, and levels of HK2, LDHA, MMP2, and MMP9 ([Figure 2B--2L](#f2-medscimonit-26-e922900){ref-type="fig"}). Moreover, HIF1A upregulation in hypoxia-treated A549 and H1975 cells was suppressed with circ_0008193 overexpression, and this suppression was then counteracted by restoring miR-1180-3p ([Supplementary Figure 1B](#s1-medscimonit-26-e922900){ref-type="supplementary-material"}). Thus we propose a tumor-suppressive role of circ_0008193 in hypoxic LUAD cells*in vitro*.

Circ_0008193 could regulate miR-1180-3p expression via physically binding
-------------------------------------------------------------------------

Previously, studies showed that circRNAs could serve as ceRNAs to sponge miRNAs \[[@b24-medscimonit-26-e922900]\]. Here, we attempted to confirm a potential direct relationship between circ_0008193 and miRNAs, and miR-1180-3p possessed the highest score according to circBank (*<http://www.circbank.cn/hsa_0008193-mirnasl>*) prediction algorithm. The putative binding sites in circ_0008193 were presented as shown in [Figure 3A](#f3-medscimonit-26-e922900){ref-type="fig"}. Dual-luciferase reporter assay manifested a significant decrease of relative luciferase activity in A549 and H1975 cells introduced with circ_0008193-WT and miR-1180-3p mimic ([Figure 3B, 3C](#f3-medscimonit-26-e922900){ref-type="fig"}); in addition, circ_0008193 and miR-1180-3p were concurrently enriched in Ago2-RIP ([Figure 3D, 3E](#f3-medscimonit-26-e922900){ref-type="fig"}). Expression of miR-1180-3p was also suppressed in circ_0008193-overexpressed A549 and H1975 cells ([Figure 3F, 3G](#f3-medscimonit-26-e922900){ref-type="fig"}). The aforementioned data suggest a target relationship between circ_0008193 and miR-1180-3p. Expression of miR-1180-3p in LUAD was measured, and RT-qPCR data showed a higher expression of miR-1180-3p in both LUAD tumor samples (*n*=53) and cell samples (A549 and H1975) ([Figure 3H, 3J](#f3-medscimonit-26-e922900){ref-type="fig"}), and an even higher level in hypoxia-treated A549 and H1975 ([Figure 3J, 3K](#f3-medscimonit-26-e922900){ref-type="fig"}). These results indicated a promising association between circ_0008193 and miR-1180-3p in tumor cell progression in LUAD.

Inhibited miR-1180-3p mediated the tumor-suppressive role of circ_0008193 in LUAD cells under hypoxia*in vitro*
---------------------------------------------------------------------------------------------------------------

The impact of miR-1180-3p expression on the role of circ_0008193 in LUAD cells was verified as follows. Hypoxic A549 and H1975 cells were pretransfected with circ_0008193 alone or combined with miR-1180-3p mimic. Endogenous miR-1180-3p expression was highly induced by hypoxia treatment, which was depressed by circ_0008193 ectopic expression ([Figure 4A](#f4-medscimonit-26-e922900){ref-type="fig"}); this inhibition of circ_0008193 on miR-1180-3p expression was rescued with exogenous administration of miR-1180-3p mimic. Downregulation of miR-1180-3p mediated by circ_0008193 transfection suppressed hypoxia-induced cell viability, glucose consumption, lactate production, and HK2 and LDHA expression in A549 and H1975 cells ([Figure 4B--4F](#f4-medscimonit-26-e922900){ref-type="fig"}). In addition, blocking miR-1180-3p expression by circ_0008193 transfection resulted in low abilities of cell migration and invasion of hypoxic A549 and H1975 cells, as described by a decrease in migrating and invading cells, as well as MMP2 and MMP9 expression ([Figure 4G--4J](#f4-medscimonit-26-e922900){ref-type="fig"}). Moreover, introduction of miR-1180-3p mimic could in turn block the suppressive role of circ_0008193 in cell proliferation, migration, invasion, and Warburg effect of A549 and H1975 cells ([Figure 4B--4J](#f4-medscimonit-26-e922900){ref-type="fig"}). The inhibition of circ_0008193 upregulation on HIF1A expression was also abrogated by restoring miR-1180-3p ([Supplementary Figure 1B](#s1-medscimonit-26-e922900){ref-type="supplementary-material"}). Therefore, we concluded that the suppressive role of circ_0008193 in LUAD cells under hypoxia *in vitro* was dependent on miR-1180-3p downregulation.

TRIM62 was a downstream target for miR-1180-3p and was modulated by circ_0008193 via miR-1180-3p
------------------------------------------------------------------------------------------------

We further explored the downstream functional gene of miR-1180-3p. According to TargetScan (*<http://www.targetscan.org/miR-1180-3p-TRIM62>*) prediction algorithm, TRIM62 3′-UTR possessed the potential binding sites of miR-1180-3p ([Figure 5A](#f5-medscimonit-26-e922900){ref-type="fig"}). Dual-luciferase reporter assay manifested a significant decrease of relative luciferase activity of the vector carrying TRIM62 3′-UTR-WT in A549 and H1975 cells introduced with miR-1180-3p mimic ([Figure 5B, 5C](#f5-medscimonit-26-e922900){ref-type="fig"}). Expression of TRIM62 protein was also suppressed in miR-1180-3p-overexpressed A549 and H1975 cells ([Figure 5D, 5E](#f5-medscimonit-26-e922900){ref-type="fig"}). The aforementioned data suggest a direct target relationship between miR-1180-3p and TRIM62. Expression of TRIM62 in LUAD was also measured, and western blotting data showed a lower expression of TRIM62 in both LUAD tumor samples (*n*=53) and cell samples (A549 and H1975) ([Figure 5F, 5G](#f5-medscimonit-26-e922900){ref-type="fig"}), and an even lower expression of TRIM62 in hypoxia-treated A549 and H1975 ([Figure 5H, 5I](#f5-medscimonit-26-e922900){ref-type="fig"}). TRIM62 expression was higher in circ_0008193-upregulated cells, and this upregulation was abrogated by the presence of miR-1180-3p mimic ([Figure 5J, 5K](#f5-medscimonit-26-e922900){ref-type="fig"}). These results indicated a promising association among circ_0008193, miR-1180-3p, and TRIM62 in tumor cell progression in LUAD.

Elevated TRIM62 mediated the suppressive role of circ_0008193 in LUAD cells under hypoxia*in vitro*
---------------------------------------------------------------------------------------------------

The impact of TRIM62 expression on the role of circ_0008193 in LUAD cells was verified as well. Hypoxic A549 and H1975 cells were pretransfected with circ_0008193 alone or combined with si-TRIM62. Endogenous TRIM62 expression was expressed at low levels in response to hypoxia, which was elevated by circ_0008193 ectopic expression; this enhancement of circ_0008193 on TRIM62 expression was counteracted by exogenous administration of si-TRIM62 ([Figure 6A](#f6-medscimonit-26-e922900){ref-type="fig"}). TRIM62 upregulation mediated by circ_0008193 overexpression via transfection suppressed hypoxia-induced cell viability ([Figure 6B](#f6-medscimonit-26-e922900){ref-type="fig"}), glucose consumption ([Figure 6C](#f6-medscimonit-26-e922900){ref-type="fig"}), lactate production ([Figure 6D](#f6-medscimonit-26-e922900){ref-type="fig"}), HK2 and LDHA expression ([Figure 6E, 6F](#f6-medscimonit-26-e922900){ref-type="fig"}), and migrating and invading cells ([Figure 6G, 6H](#f6-medscimonit-26-e922900){ref-type="fig"}), as well as MMP2 and MMP9 expression ([Figure 6I, 6J](#f6-medscimonit-26-e922900){ref-type="fig"}) in A549 and H1975 cells. In addition, restoring TRIM62 expression could in turn block the suppressive role of circ_0008193 in cell proliferation, migration, invasion, and Warburg effect of A549 and H1975 cells ([Figure 6B--6J](#f6-medscimonit-26-e922900){ref-type="fig"}). The inhibition of circ_0008193 upregulation on HIF1A expression was also abrogated by silencing TRIM62 ([Supplementary Figure 1C](#s1-medscimonit-26-e922900){ref-type="supplementary-material"}). Therefore, we proposed that the suppressive role of circ_0008193 in LUAD cells under hypoxia *in vitro* was dependent on TRIM62 upregulation.

Overexpressed circ_0008193 hindered tumor growth of LUAD cells *in vivo*
------------------------------------------------------------------------

*In vivo*, we intended to study the effect of circ_0008193 on tumorigenicity of A549 cells in mice. As shown in [Figure 7A--7C](#f7-medscimonit-26-e922900){ref-type="fig"}, A549 cells induced neoplasms in nude mice; the tumor volume and weight of circ_0008193 group (*n*=4) were less than the vector group (*n*=4). Notably, the neoplasms injected with circ_0008193 overexpression vectors exhibited significantly higher circ_0008193 ([Figure 7D](#f7-medscimonit-26-e922900){ref-type="fig"}) and TRIM62 ([Figure 7F, 7G](#f7-medscimonit-26-e922900){ref-type="fig"}) and lower miR-1180-3p ([Figure 7E](#f7-medscimonit-26-e922900){ref-type="fig"}). These outcomes indicated that circ_0008193 upregulation hindered tumor growth of A549 cells *in vivo* via downregulating miR-1180-3p and upregulating TRIM62.

Discussion
==========

Hypoxia always occurs in the pathology of cancers. In response to hypoxia, a large number of target genes are activated, and HIF1A is one key pathway under hypoxic signaling and adaptation through targeting special genes \[[@b25-medscimonit-26-e922900]\] such as forkhead box C1 and glycogen branching enzyme \[[@b26-medscimonit-26-e922900],[@b27-medscimonit-26-e922900]\]. Dozens of circRNAs have also been declared to be significantly abundantly altered upon hypoxia in cervical, breast, and lung cancer cells *in vitro* \[[@b28-medscimonit-26-e922900]\]. Moreover, the circRNA expression profile was comprehensively compared in A549 cells under normoxia and hypoxia \[[@b29-medscimonit-26-e922900]\]. Since hypoxia is crucial to the initiation and progression of tumor metastasis, several circRNAs have been demonstrated to participate in LUAD cell migration and invasion. For example, circ_0000211 and circ_0014130 were shown to facilitate LUAD cell endothelial-to-mesenchymal transition (EMT), wound-healing ability, and transwell migration and invasion properties by positively modulating HIF1A \[[@b30-medscimonit-26-e922900],[@b31-medscimonit-26-e922900]\]. Upregulating circCCDC66 was associated with hypoxia-induced EMT and epidermal growth factor receptor resistance in LUAD cells \[[@b32-medscimonit-26-e922900]\]. Here, we explored the effect of circ_0008193 on cell proliferation, migration, invasion, and Warburg effect in LUAD cells via the miR-1180-3p/TRIM62 axis.

We observed that circ_0008193 was significantly downregulated in LUAD tumor tissues and cell lines, as well as in hypoxia-treated A549 and H1975 cells (with HIF1A upregulation). These data agreed with a previous study \[[@b29-medscimonit-26-e922900]\]. In this study, we further examined the biologic role of circ_0008193 in LUAD cells. As a result, we indicate that overexpression of circ_0008193 could inhibit hypoxia-induced cell viability, glucose consumption, lactate production, and HK2 and LDHA expression, as well as diminish transwell migration and invasion abilities and MMP2 and MMP9 expression. By these observations, this study suggests that clinically, circ_0008193 is a novel promising target of hypoxic LUAD. The growth of neoplasms mediated by A549 cells was restrained by circ_0008193 overexpression *in vivo*. With inspiration from the prediction of target miRNAs by Cheng et al. \[[@b29-medscimonit-26-e922900]\], we chose miR-1180-3p for further confirmation. Here, we observed that HIF1A upregulation in hypoxia-treated A549 and H1975 cells led to circ_0008193 inhibition (as well as miR-1180-3p promotion), and overexpressing circ_0008193 caused HIF1A downregulation (accompanied by miR-1180-3p deficiency). These findings suggest that expression of circ_0008193 and miR-1180-3p in LUAD is a HIF1A-dependent mechanism.

MiR-1180-3p was suggested to be one essential plasma biomarker to distinguish gastric cancer from benign gastritis, and to distinguish early gastric cancer from advanced gastric cancer \[[@b33-medscimonit-26-e922900]\]. This miRNA was also used to discriminate hepatocellular carcinoma (HCC) occurrence after direct antiviral therapy \[[@b34-medscimonit-26-e922900]\]. In lung cancer, miR-1180-3p was previously discovered to be upregulated in the sera and tumor tissues from lung cancer patients and was correlated with higher TNM stage and poor overall survival \[[@b35-medscimonit-26-e922900]\]. Here, our data supported the upregulation of miR-1180-3p in LUAD tissues and cell lines, and even higher expression of miR-1180-3p was observed in hypoxia-treated A549 and H1975 cells (with HIF1A upregulation). Similarly, this miRNA was a common target for different ceRNAs (such as long noncoding RNA DGCR5 \[[@b35-medscimonit-26-e922900]\] and circ_0008193) to affect the proliferation, migration, and invasion of NSCLC cells. Furthermore, we validated that miR-1180-3p upregulation was one molecular mechanism of hypoxia-induced cell proliferation, migration, invasion, and Warburg effect. Notably, TRIM62 was identified as a functional target gene of miR-1180-3p. In addition, miR-1180-3p could exert anti-apoptotic function in HCC through targeting OTUD7B, TNIP2, and BAD, which were key inhibitors of the NF-κB signaling pathway and proapoptosis protein \[[@b36-medscimonit-26-e922900]\]. However, the effect of the circ_0008193/miR-1180-3p/TRIM62 axis on cell apoptosis was not determined in this study, and this could be another direction of our study.

HK2 and LDHA were direct target glycolytic enzymes of HIF1 \[[@b37-medscimonit-26-e922900]\]. MMP2 and MMP9 expression was in a HIF1-dependent manner \[[@b38-medscimonit-26-e922900]\]. In this present study, we identified TRIM62 as a target of miR-1180-3p associated with HIF1A expression in hypoxic LUAD cells. TRIM62, as a RING finger E3 ubiquitin ligase, has been an adverse prognostic biomarker in different cancers. For example, Lott et al. claimed that TRIM62 was an independent predictor of survival of early-onset breast cancer, cervical cancer, and acute myeloid leukemia \[[@b16-medscimonit-26-e922900],[@b17-medscimonit-26-e922900],[@b39-medscimonit-26-e922900]\]. The physiological mechanism of TRIM62 in cancer is partially by working as a master regulator of EMT and cell polarity \[[@b17-medscimonit-26-e922900],[@b40-medscimonit-26-e922900],[@b41-medscimonit-26-e922900]\]. However, we did not investigate the effect of the circ_0008193/miR-1180-3p/TRIM62 axis on EMT, even though transwell migration and invasion properties have been observed. In lung cancer, TRIM62 loss cooperated with K-*ras* mutation in promoting lung cancer cell metastasis *in vivo* \[[@b18-medscimonit-26-e922900]\]. Here, we also noticed a silencing of TRIM62 in LUAD patients and cell lines, and even lower expression of TRIM62 in hypoxia-treated A549 and H1975 cells. Functionally, downregulating TRIM62 was one molecular mechanism of hypoxia-induced cell proliferation, migration, invasion, and Warburg effect. The deletion of TRIM62 was also associated with hypoxia-involved proteins including HIF1A and glucose-related protein 78 in acute myeloid leukemia \[[@b39-medscimonit-26-e922900]\]. Here, we observed that HIF1A upregulation in hypoxia-treated A549 and H1975 cells induced inhibition of TRIM62 expression, and the high level of TRIM62 mediated by circ_0008193 caused HIF1A downregulation. This finding suggested a reciprocal inhibitory effect between HIF1A and TRIM62. However, whether TRIM62 is a novel target of HIF1A remains to be determined. Meanwhile, the relationship between TRIM62 and MMP2, MMP9, HK2, or LDHA before this research was unknown. We declared a negative regulatory effect of TRIM62 on levels of MMP2, MMP9, HK2, and LDHA in LUAD cells under hypoxia *in vitro*. Its underlying mechanism should be further explored.

Conclusions
===========

Collectively, we demonstrated that circ_0008193 served as a tumor suppressor in LUAD. Overexpression of circ_0008193 suppressed cell proliferation, migration, invasion, and Warburg effect of LUAD cells under hypoxia*in vitro* and *in vivo* through promoting TRIM62 via miR-1180-3p. This study suggested a novel circ_0008193/miR-1180-3p/TRIM62 axis underlying the molecular mechanism of hypoxic LUAD.

Supplementary Data
==================

###### 

Expression of hypoxia-inducible factor 1 alpha (HIF1A) in human lung adenocarcinoma (LUAD) cells under hypoxia *in vitro*. (**A--C**) Real-time quantitative polymerase chain reaction (RT-qPCR) detected HIF1A messenger ribonucleic acid (mRNA) level in (**A**) A549 and H1975 cells treated with hypoxia for 48 h or not, and hypoxia-treated A549 and H1975 cells pretransfected with empty vector (vector) alone, vector carrying circ_0008193 (circ_0008193) alone or together with (**B**) miR-1180-3p mimic (miR-1180-3p) or miR-NC mimic (miR-NC), and (**C**) small interfering (si)RNA against TRIM62 (si-TRIM62) or its negative control (si-NC). \* *P*\<0.05 from three independent experiments.
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![Expression of circ_0008193 in human lung adenocarcinoma (LUAD) tumor tissues and cells. Real-time quantitative polymerase chain reaction (RT-qPCR)-measured circ_0008193 expression level in (**A**) tissues from LUAD patients (*n*=53) and (**B**) LUAD cell lines. (**C, D**) RT-qPCR-compared circ_0008193 and its parent gene FAM120A levels in A549 and H1975 cells. (**E**) Kaplan-Meier analysis tested the overall survival of these LUAD patients divided into low group (*n*=27) and high group (*n*=26) according to circ_0008193 expression level. (**F, G**) RT-qPCR-detected circ_0008193 level in hypoxic A549 and H1975 cells. \*\*\* *P*\<0.001 from three independent experiments.](medscimonit-26-e922900-g001){#f1-medscimonit-26-e922900}

![Effect of circ_0008193 overexpression in human lung adenocarcinoma (LUAD) cells under hypoxia *in vitro*. (**A**) Real-time quantitative polymerase chain reaction (RT-qPCR)-confirmed circ_0008193 level in hypoxic A549 and H1975 cells transfected with vectors carrying circ_0008193 or not (vector or circ_0008193). (**B**) 3-(4, 5-Dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide (MTT) assay evaluated cell viability; (**C, D**) special kits assessed glucose and lactate concentrations; (**E, F**) western blotting measured hexokinase II (HK2) and lactate dehydrogenase A (LDHA) expression; (**G--J**) transwell determined numbers of migrating and invading cells; (**K, L**) western blotting also measured matrix metalloproteinase 2 (MMP2) and MMP9 levels in transfected A549 and H1975 cells after hypoxia treatment for 48 h. \*\*\* *P*\<0.001 from three independent experiments.](medscimonit-26-e922900-g002){#f2-medscimonit-26-e922900}

![Relationship between circ_0008193 and micro (mi)RNA (miR)-1180-3p in human lung adenocarcinoma (LUAD) tissues and cells. (**A**) Wild type of circ_0008193 (circ_0008193-WT) was predicted to contain potential binding sites of miR-1180-3p. (**B, C**) Dual-luciferase reporter assay identified luciferase activity of vectors carrying circ_0008193-WT or mutant type circ_0008193-MUT. (**D, E**) Ribonucleic acid (RNA) immunoprecipitation validated the enriched levels of circ_0008193 and miR-1180-3p. (**F, G**) Real-time quantitative polymerase chain reaction (RT-qPCR) examined miR-1180-3p level in A549 and H1975 cells in the presence of vector or circ_0008193. RT-qPCR measured miR-1180-3p expression status in (**H**) tissues from patients (*n*=53) with LUAD and (**I**) LUAD cell lines. (**J, K**) RT-qPCR detected miR-1180-3p level in hypoxic A549 and H1975 cells. \*\*\* *P*\<0.001 from three independent experiments.\
Groupingp Values**B**miR-NC-miR-1180-3pcirc_0008193WT0.0002circ_0008193MUT0.7676**C**miR-NC-miR-1180-3pcirc_0008193 WT\<0.0001circ_0008193 MUT0.7761**D**circ_0008193Input *vs.* Anti-Ago2\<0.0001Input *vs.* Anti-IgG\<0.0001Anti-Ago2 *vs.* Anti-IgG\<0.0001miR-1180-3pInput *vs.* Anti-Ago2\<0.0001Input *vs.* Anti-IgG\<0.0001Anti-Ago2 *vs.* Anti-IgG\<0.0001**E**circ_0008193Input *vs.* Anti-Ago2\<0.0001Input *vs.* Anti-IgG\<0.0001Anti-Ago2 *vs.* Anti-IgG\<0.0001miR-1180-3pInput *vs.* Anti-Ago2\<0.0001Input *vs.* Anti-IgG\<0.0001Anti-Ago2 *vs.* Anti-IgG\<0.0001**F**circ_0008193 *vs.* vector0.0002**G**circ_0008193 *vs.* vector0.0005**H**Tumor *vs.* mormal\<0.0001**I**BEAS-2B *vs.* A549\<0.0001BEAS-2B *vs.* H1975\<0.0001**J**48 h *vs.* 0 h\<0.0001**K**48 h *vs.* 0 h\<0.0001](medscimonit-26-e922900-g003){#f3-medscimonit-26-e922900}

![Impact of miR-1180-3p expression on the role of circ_0008193 in human lung adenocarcinoma (LUAD) cells under hypoxia*in vitro*. (**A**) Real-time quantitative polymerase chain reaction (RT-qPCR) confirmed miR-1180-3p level in hypoxic A549 and H1975 cells cotransfected with circ_0008193 and miR-1180-3p mimic (miR-1180-3p) or its control miR-NC. (**B**) 3-(4, 5-Dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide (MTT) assay evaluated cell viability; (**C, D**) special kits assessed glucose and lactate concentrations; (**E, F**) western blotting measured hexokinase II (HK2) and lactate dehydrogenase A (LDHA) expression; (**G, H**) transwell determined numbers of migrating and invading cells; (**I, J**) western blotting also measured metalloproteinase (MMP)2 and MMP9 levels in transfected A549 and H1975 cells after hypoxia treatment for 48 h. \*\*\* *P*\<0.001 from three independent experiments.](medscimonit-26-e922900-g004){#f4-medscimonit-26-e922900}

![Relationship between miR-1180-3p and tripartite motif containing 62 (TRIM62) in human lung adenocarcinoma (LUAD) tissues and cells. (**A**) Wild type of TRIM62 3′-untranslated region (TRIM62 3′-UTR-WT) was predicted to contain potential binding sites of miR-1180-3p. (**B, C**) Dual-luciferase reporter assay identified luciferase activity of vectors carrying TRIM62 3′-UTR-WT or mutant type (TRIM62 3′-UTR-MUT). (**D, E**) Western blotting measured TRIM62 expression in A549 and H1975 cells in the presence of miR-1180-3p or miR-NC. (**F**) Western blotting identified TRIM62 expression in tissues from LUAD patients (*n*=53), and three representative images (N1-3 and T1-3) are shown. (**G**) Western blotting identified TRIM62 expression in LUAD cell lines. (**H, I**) Western blotting detected TRIM62 level in hypoxic A549 and H1975 cells. (**J, K**) Western blotting detected TRIM62 level in A549 and H1975 cells in the presence of vector or circ_0008193 and copresence of circ_0008193 and miR-NC or miR-1180-3p. \*\*\* *P*\<0.001 from three independent experiments.](medscimonit-26-e922900-g005){#f5-medscimonit-26-e922900}

![Impact of tripartite motif containing 62 (TRIM62) expression on the role of circ_0008193 in human lung adenocarcinoma (LUAD) cells under hypoxia*in vitro*. (**A**) Western blotting confirmed TRIM62 level in hypoxic A549 and H1975 cells cotransfected with circ_0008193 and small interfering ribonucleic acid (siRNA) against TRIM62 (si-TRIM62) or its control si-NC. (**B**) 3-(4, 5-Dimethylthiazol-2-yl)-2, 5 diphenyltetrazolium bromide (MTT) assay evaluated cell viability; (**C, D**) special kits assessed glucose and lactate concentrations; (**E, F**) western blotting measured hexokinase II (HK2) and lactate dehydrogenase A (LDHA) expression; (**G, H**) transwell determined numbers of migrating and invading cells; (**I, J**) western blotting also measured metalloproteinase (MMP)2 and MMP9 levels in transfected A549 and H1975 cells after hypoxia treatment for 48 h. \* *P*\<0.05 and \*\*\* *P*\<0.001 from three independent experiments.](medscimonit-26-e922900-g006){#f6-medscimonit-26-e922900}

![Effect of circ_0008193 overexpression on growth of A549 cells *in vivo*. A549 cells were subcutaneously implanted in BALB/c nude mice and then intratumorally injected with circ_0008193 (*n*=4) or vector (*n*=4) every 3.5 days. (**A**) Tumor volume was measured every 7 days. (**B**) Tumor weight was measured on day 35. (**C**) Images of xenograft tumors are presented. (**D--F**) Real-time quantitative polymerase chain reaction (RT-qPCR) confirmed the expression of circ_0008193, miR-1180-3p, and tripartite motif containing 62 (TRIM62) messenger ribonucleic acid (mRNA) in neoplasm tissues. (**G**) Western blotting validated TRIM62 protein expression in neoplasm tissues. \*\*\* *P*\<0.001 from three independent experiments.](medscimonit-26-e922900-g007){#f7-medscimonit-26-e922900}

###### 

Correlation between hsa_circ_0008193 (FAM120A) level and pathological indexes of lung adenocarcinoma patients.

  Parameter               Case   hsa_circ_0008193 expression   *P* value[\#](#tfn2-medscimonit-26-e922900){ref-type="table-fn"}   
  ----------------------- ------ ----------------------------- ------------------------------------------------------------------ ---------------------------------------------------------------
  Age (years)                                                                                                                     0.5009
   ≤60                    32     18                            14                                                                 
   \>60                   21     9                             12                                                                 
  Gender                                                                                                                          0.4999
   Male                   23     10                            13                                                                 
   Female                 30     17                            13                                                                 
  Smoking                                                                                                                         0.5076
   Yes                    29     14                            15                                                                 
   No                     24     10                            14                                                                 
  Tumor size                                                                                                                      0.0026[\*](#tfn1-medscimonit-26-e922900){ref-type="table-fn"}
   ≤3 cm                  20     16                            4                                                                  
   \>3 cm                 33     11                            22                                                                 
  Lymph node metastasis                                                                                                           0.0010[\*](#tfn1-medscimonit-26-e922900){ref-type="table-fn"}
   No                     35     24                            11                                                                 
   Yes                    18     3                             15                                                                 

*P*\<0.05.

Chi-square test.
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